Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Carter Berezay who wrote (557)	8/29/1999 12:59:00 PM
From: Sean Janzen	Respond to of 792

MBI does not have a separate addresses for news releases. Here's a copy of the paragraph you mention, "It was important to Micrologix not only to have a strong syndicate assemble the financing but also one that is aligned with, and supports the Company's long-term financial strategy" said Mr. Hadary. "To this end, we have granted three of the underwriters special After-Market Support Options. Holders of these options may purchase up to 769,250 common shares of Micrologix, in three equal six-month tranches, at exercise prices escalating from $3.25 per common share in the first six-month tranche, to $5.50 per common share in the third six-month tranche."